Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the
United States population. This guideline addresses important clinical questions that arise in …

Purpose To summarize the data published over the last 5 years in the European Union
related to the health-related quality of life (HRQoL) of patients with psoriasis and its …

The advances in psoriasis management currently allow achieving a good control of the
disease. In particular, with the latest developed molecules, available evidence suggests that …

Background Psoriasis is a common skin disease and moderate to severe psoriasis is
associated with a dose-dependent risk for metabolic and cardiovascular morbidity. It has …

Background Psoriasis critically influences the psychosocial well-being of patients and
reduces their quality of life and work efficiency beyond skin symptoms. However, evidence …

Summary Background 'Not relevant'responses (NRRs) on the Dermatology Life Quality
Index (DLQI) may occur in up to 40% of patients with psoriasis. As these responses are …

Abstract Background Dermatology Life Quality Index (DLQI) is the most common health‐
related quality of life measure in dermatology that is widely used in treatment guidelines for …

The purpose of this study is to assess the measurement properties of EQ-5D-5L compared to
EQ-5D-3L in psoriasis patients. Methods A cross-sectional survey was carried out at an …

Background Plaque psoriasis significantly affects patients' health-related quality of life. To
aid treatment decisions, not only objective assessment by physicians but also subjective …

Psoriasis vulgaris is a common, chronic inflammatory skin disease with a prevalence of 1.5-
2% in Western industrialized countries. A relevant percentage of patients suffer from …